Trials / Completed
CompletedNCT06469359
Analyzes of Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC)
Development of a Methodology to Analyze Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Clinical evaluation of vaccines against respiratory viruses is currently based on the analysis of systemic immune responses, whereas respiratory immunity is the first line of defense against respiratory pathogens. In addition to secretory immunoglobulin A (IgA) in mucosal fluids which are essential to neutralize the pathogens at mucosal surfaces, tissue-resident memory immune cells have been shown to be crucial in protection. Furthermore, memory immune cells in blood able to migrate to airway tissues also play a crucial role. Airway immune responses have not been studied a lot due to the lack of a standardized methodology to evaluate them in humans.
Detailed description
The goal of this study is to develop a methodology to collect and analyze nasal tissue-resident memory T and B cells and to evaluate peripheral memory T and B cells expressing airway homing markers in healthy volunteers. Three devices for nasal cell sampling will be compared. Tissue-resident and peripheral memory immune responses will be determined using flow cytometry and correlated with humoral and cellular responses, as well as with gene expression at mucosal and systemic levels. .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nasal tissue-resident memory T and B cells | Nasal tissue-resident memory T and B cells are quantified using flow cytometry. |
| DEVICE | Nasal fluid sampling | Nasal fluid is collected using strip (Hunt Development) in both nostrils |
| DEVICE | Saliva sampling | Saliva is collected using Oracol (Malvern Medical Developments) |
| OTHER | Blood sampling | Isolation of peripheral blood mononuclear cells (PBMC) and serum from blood |
| DIAGNOSTIC_TEST | ELISA | ELISA to measure antibody responses in mucosal fluids and blood |
| DIAGNOSTIC_TEST | Neutralization test | Neutralization test to measure neutralizing antibody responses in mucosal fluids and blood to measure neutralizing antibody responses in mucosal fluids and blood |
| DIAGNOSTIC_TEST | ELISPot | ELISPot to measure cellular responses in blood |
| DIAGNOSTIC_TEST | Transcriptomics | Transcriptomics to quantify the gene expression of immunological markers in blood |
Timeline
- Start date
- 2024-07-22
- Primary completion
- 2024-11-11
- Completion
- 2024-11-11
- First posted
- 2024-06-21
- Last updated
- 2024-12-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06469359. Inclusion in this directory is not an endorsement.